Trial intelligence / Profile preview

Colesevelam in Prediabetes

NCT00990184Phase 3Completed

Sponsor
Seattle Institute for Biomedical and Clinical Research
Start
Sep 2009
Primary completion
Oct 2010
01

Overview

A Phase 3 trial of colesevelam in prediabetes, sponsored by Seattle Institute for Biomedical and Clinical Research. Started Sep 2009; status: completed.

02

Drugs

colesevelam
03

Conditions

prediabetes

Beyond the preview

Go deeper on NCT00990184.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00990184.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call